Search

Your search keyword '"Pulmonary Surfactants analysis"' showing total 1,359 results

Search Constraints

Start Over You searched for: Descriptor "Pulmonary Surfactants analysis" Remove constraint Descriptor: "Pulmonary Surfactants analysis"
1,359 results on '"Pulmonary Surfactants analysis"'

Search Results

1. Investigating the effects of dexamethasone on pulmonary surfactant lipids based on lipidomics studies.

2. Validation of a high-performance liquid chromatography method for determining lysophosphatidylcholine content in bovine pulmonary surfactant medication.

3. Towards quantifying biomarkers for respiratory distress in preterm infants: Machine learning on mid infrared spectroscopy of lipid mixtures.

4. Surfactant-enhanced air-agitation liquid-liquid microextraction of polycyclic aromatic hydrocarbons from edible oil using magnetic deep eutectic solvent prior to HPLC determination.

5. A novel deuterium-based model for measurement of exogenous surfactant using deuterium-depleted water.

6. Reduced levels of pulmonary surfactant in COVID-19 ARDS.

7. PPARγ activation in late gestation does not promote surfactant maturation in the fetal sheep lung.

8. Stimulation of surfactant exocytosis in primary alveolar type II cells by A. fumigatus.

9. Assessment of pulmonary surfactant in COVID-19 patients.

10. Determining the fluid ordered and disordered phases in a pulmonary surfactant by electron spin resonance technique.

11. Comprehensive characterization and proteoform analysis of the hydrophobic surfactant proteins B and C in calf pulmonary surfactant.

12. [PROGNOSTIC VALUE OF BLOOD AND BRONCHOALVEOLAR LAVAGE FLUIDS BIOMARKERS FOR IDIOPATHIC PULMONARY FYBROSIS (REVIEW)].

13. Mass spectrometry imaging as a tool for evaluating the pulmonary distribution of exogenous surfactant in premature lambs.

14. Rapid diagnosis of respiratory distress syndrome by oral aspirate in premature newborns.

15. Estimation of early life endogenous surfactant pool and CPAP failure in preterm neonates with RDS.

16. Irritant-induced asthma to hypochlorite in mice due to impairment of the airway barrier.

17. Quantification of surfactant proteins in tears of patients suffering from dry eye disease compared to healthy subjects.

18. Surfactant Dysfunction in ARDS and Bronchiolitis is Repaired with Cyclodextrins.

19. The effect of exhalation flow on endogenous particle emission and phospholipid composition.

20. Transcriptomic profiling reveals disordered regulation of surfactant homeostasis in neonatal cloned bovines with collapsed lungs and respiratory distress.

21. [Hyperoxia modulates the expressions of C/EBPα and pulmonary surfactant proteins in AECII of premature rats].

22. Surfactant deficiency in full-term newborns with transient tachypnea delivered by elective C-section.

23. Delineation of the dynamic properties of individual lipid species in native and synthetic pulmonary surfactants.

24. Molecular pathology analyses of two fatal human infections of avian influenza A(H7N9) virus.

25. Surfactant deficiency in infants with severe acute viral bronchiolitis.

26. Effect of sustained inflation vs. stepwise PEEP strategy at birth on gas exchange and lung mechanics in preterm lambs.

27. Effect of long-term simulated weightlessness on surfactant and water balance in mouse lungs.

28. Impaired pulmonary defense against Pseudomonas aeruginosa in VEGF gene inactivated mouse lung.

29. Surfactant therapy for acute respiratory distress in children.

30. Biochemical and biophysical investigation of surfactant in neonatal gastric aspirate at birth.

31. [Changes to surfactant proteins in the bronchoalveolar lavage fluid and serum of children with Mycoplasma pneumoniae pneumonia].

32. Regional pulmonary inflammation in an endotoxemic ovine acute lung injury model.

33. Proteomic analysis of lamellar bodies isolated from amniotic fluid: implications for function.

35. Lamellar body count and stable microbubble test on tracheal aspirates from infants for the diagnosis of respiratory distress syndrome.

36. [Study of the lung surfactant maturity by biochemical and biophysical analyses of gasral aspirates from newborn infants].

37. Epithelial regeneration after diffuse alveolar damage in relation to underlying disease and DAD stage: an autopsy study.

38. Surfactant deficiency in transient tachypnea of the newborn.

39. Metabolomic analysis of bronchoalveolar lavage fluid in preterm infants complicated by respiratory distress syndrome: preliminary results.

40. Contemporary issues in fetal lung maturity testing.

41. Diffuse lung disease in children.

42. Biomarker tests for fetal lung maturity.

43. Clinical and laboratory trends in fetal lung maturity testing.

44. [Comparative analysis of amniotic fluid lamellar body count and foam stability test as indices of fetal lung maturity].

45. Amniotic lamellar body counts determined with the Sysmex XE-2100 analyzer to predict fetal lung maturity during diabetic and other complicated pregnancies.

46. [Lamellar body count in amniotic fluid for assessing fetal lung maturity].

47. Validation of lamellar body counts using three hematology analyzers.

48. Antenatal consent in the SUPPORT trial: challenges, costs, and representative enrollment.

49. The ways of amniotic fluid sampling and its influence on lamellar body count.

50. Dose-response effects of betamethasone on maturation of the fetal sheep lung.

Catalog

Books, media, physical & digital resources